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ABSTRACT
Objective To estimate future palliative care need and 
complexity of need in Scotland, and to identify priorities for 
future service delivery.
Design We estimated the prevalence of palliative care 
need by analysing the proportion of deaths from defined 
chronic progressive illnesses. We described linear 
projections up to 2040 using national death registry data 
and official mortality forecasts. An expert consultation 
and subsequent online consensus survey generated 
recommendations on meeting future palliative care need.
Setting Scotland, population of 5.4 million.
Participants All decedents in Scotland over 11 years 
(2007 to 2017). The consultation had 34 participants; 24 
completed the consensus survey.
Primary and secondary outcomes Estimates of past 
and future palliative care need in Scotland from 2007 up to 
2040. Multimorbidity was operationalised as two or more 
registered causes of death from different disease groups 
(cancer, organ failure, dementia, other). Consultation and 
survey data were analysed descriptively.
Results We project that by 2040, the number of people 
requiring palliative care will increase by at least 14%; 
and by 20% if we factor in multimorbidity. The number 
of people dying from multiple diseases associated with 
different disease groups is projected to increase from 
27% of all deaths in 2017 to 43% by 2040. To address 
increased need and complexity, experts prioritised 
sustained investment in a national digital platform, roll- out 
of integrated electronic health and social care records; and 
approaches that remain person- centred.
Conclusions By 2040 more people in Scotland are 
projected to die with palliative care needs, and the 
complexity of need will increase markedly. Service 
delivery models must adapt to serve growing demand 
and complexity associated with dying from multiple 
diseases from different disease groups. We need sustained 
investment in secure, accessible, integrated and person- 
centred health and social care digital systems, to improve 
care coordination and optimise palliative care for people 
across care settings.
BACKGROUND
Worldwide, deaths are expected to rise from 
55 million in 2016 to 75 million by 2040.1 
Non- communicable diseases accounted for 
72% of global deaths in 2016, and are fore-
cast to account for 81% of deaths by 2040.1 
Globally, the proportion of people aged 80 or 
over increased by 76.5% between 2000 and 
2015.2 The growing number of older people 
and increased prevalence of chronic condi-
tions indicate that more people would benefit 
from a palliative approach to care over the 
next two decades.
Demographic changes and shifts in disease 
patterns at a national level will impact popula-
tion palliative care need. An analysis based on 
data from 2006 to 2014 in England and Wales, 
projected that up to 87.6% of people who die 
could benefit from palliative care by 2040.3 In 
Ireland, a similar analysis based on data from 
2007 to 2015, projected that palliative care 
Strengths and limitations of this study
 ► First study to project estimates of future palliative 
care need for Scotland.
 ► Used a range of estimation methods, accounting for 
both underlying and contributory causes of death, to 
produce robust projections.
 ► The expert consultation and consensus survey en-
sured that recommendations were grounded in 
practice.
 ► We drew on death registry data that relies on accu-
rate completion of death certificates.
 ► Our definition of multimorbidity was relatively re-
strictive—decedents were required to have two ma-
jor illnesses from different disease groups, both of 
which would individually confer palliative care need.
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need will increase, and will be indicated for 83% of those 
who die by 2046.4 However, existing projection studies 
use data based on ‘main underlying cause of death’ only, 
excluding people who may have had a contributory cause 
of death (but not a main underlying cause) associated 
with palliative care need. Models that only use ‘main 
underlying cause of death’ may therefore underestimate 
the true extent of population palliative care need; models 
that incorporate both main underlying and contributory 
causes of death are required.
Increased longevity in developed and developing coun-
tries comes with greater multimorbidity. Multimorbidity 
describes the co- existence of two or more chronic condi-
tions which may be a physical non- communicable disease, 
a mental health condition or infectious disease of long 
duration.5 6 Data from Scotland has shown that 65% of 
people aged 65 to 84 years have two or more long- term 
disorders; rising to 81.5% for people aged 85 and over.7 
Only 5.3% of people with dementia have no other long- 
term disorder.8 Despite the recognition that multimor-
bidity is the norm in high- income countries,5 there has 
been little consideration of the implications for palliative 
care. To inform future palliative care service design, there 
is a need to better understand multimorbidity due to the 
presence of advanced progressive diseases. As a starting 
point, we need estimates of the number of people dying 
from multiple diseases associated with palliative care need 
now and in the future.
The aim of this study was to estimate, and project future 
palliative care need and complexity of need in Scotland up 
to 2040. Extending previous work, we sought to estimate 
and project the number of people dying from more than 
one disease associated with palliative care need. Further-
more, we planned an expert consultation and consensus 
survey to generate recommendations for future palliative 
care service delivery. This novel analysis sought to provide 
a more comprehensive picture of future palliative care 
need, and complexity of need, than previously described.
METHODS
Design
Mixed methods consisting of: (1) simple linear modelling 
of routinely available national death registry data and 
mortality projections for Scotland and (2) expert consul-
tation and online consensus survey to generate recom-
mendations for service design and delivery based on our 
projections.
Setting
Scotland is a high- income Western European country 
with a population of 5.4 million; 57 870 people died in 
2017.9 Mortality forecasts project that annual deaths will 
increase by 13.6% to 65 756 by 2040.10
Data sources
Deaths by age, gender and cause from 2007 to 2017
We obtained aggregate level data on deaths by age, gender 
and cause for an 11- year period (2007 to 2017 inclusive) 
from Public Health Scotland (previously known as Informa-
tion Services Division Scotland). The aggregate data were 
derived from the National Records of Scotland individual- 
level deaths database held by Public Health Scotland.
Mortality projections for Scotland are available from the 
Office for National Statistics and National Records of 
Scotland.10 11 The mortality projections used in this anal-
ysis were based on the 2016 principal population projec-
tions for Scotland up to 2040. We used projections up to 
2040 to allow comparison with studies in other countries.
Generating estimates of population palliative care need
Palliative care need at a population level has been esti-
mated using a variety of methods. Gómez- Batiste et al esti-
mated that 75% of all those who die have palliative care 
needs.12
Other approaches use disease- specific mortality data 
and identify diseases using International Classification 
of Disease - 10th Revision (ICD-10) codes associated with 
palliative care need to generate estimates.13 14 Murtagh 
et al estimated that in high- income countries, 63% to 
97% of people who die might benefit from palliative care 
depending on the estimation method used.14 Based on 
this previous work, we estimated and projected palliative 
care need in three ways as described below.
Estimation method 1: 75% of all deaths
Method 1 is based on that used by Gómez- Batiste et al.12 
It assumes that 75% of people in high- income coun-
tries die from chronic progressive diseases with evolving 
and increasing healthcare needs. Consequently, 75% of 
people at the end of life may benefit from a palliative 
care approach, irrespective of whether that is delivered 
by palliative care specialists or other health professionals. 
We calculated palliative care need as 75% of all deaths in 
2017, and projected this proportion up to 2040.
Estimation method 2: palliative care need based on ICD-10 codes 
associated with main underlying cause of death
Method 2 takes a diagnosis- based approach, applying 
ICD-10 diagnostic codes previously used to estimate 
population palliative care need (online supplemental file 
1).3 14 To project future palliative care need, we modelled 
two scenarios (2A and 2B). For method 2A, we calculated 
the number and proportion of age and gender- specific 
deaths in 2017 where an ICD-10 code associated with 
palliative care was recorded as the main underlying cause 
of death, then applied this proportion to mortality fore-
casts for each year up to 2040, with no adjustments. For 
method 2B we calculated the mean annual change in the 
proportion of deaths requiring palliative care between 
2007 and 2017. We assumed the mean annual change 
would continue in a linear fashion and applied the 
resulting proportion to mortality forecasts up to 2040. We 
copyright.
 on F











pen: first published as 10.1136/bm





3Finucane AM, et al. BMJ Open 2021;11:e041317. doi:10.1136/bmjopen-2020-041317
Open access
chose method 2B for subanalyses projecting future needs 
by age and disease group as it enabled comparison with 
data reported in other published studies.3 4
Estimation method 3: palliative care need based on ICD-10 codes 
associated with main underlying and all contributory cause(s) of 
death
Method 3 adopts a diagnostic- based approach, using the 
same ICD-10 diagnostic codes outlined in method 2 to 
estimate the number of people dying from diseases asso-
ciated with palliative care need. However, for method 3, 
our estimate of palliative care need was the number of 
people for whom a palliative care relevant disease was 
recorded as either the main underlying cause of death, 
or a contributory cause. Thus, method 3 should yield 
the most accurate and comprehensive estimate of deaths 
associated with palliative care need in a calendar year. 
To project future need using this method, we calculated 
the number and proportion of age and gender- specific 
deaths from 2007 to 2017 where an ICD-10 code associ-
ated with palliative care was recorded, as either the main 
underlying or contributory cause of death. As for method 
2B, we assumed the mean annual change in the propor-
tion of deaths associated with palliative care need over 
the baseline period would continue to occur in a linear 
fashion, and applied the resulting mean annual change 
to mortality forecasts up to 2040.
Defining, estimating and projecting multimorbidity associated 
with advanced progressive diseases
We wanted to estimate and project the number of people 
dying from multimorbidity associated with palliative 
care need. Given that some diseases are closely related 
and may represent similar disease processes (e.g. related 
cancers), we chose to define multimorbidity as people 
dying from two or more chronic diseases associated 
with palliative care need from more than one of four 
disease groups—cancer, organ failure, dementia or other 
(includes neurological conditions and stroke). This defi-
nition indicates care complexity, given the distinct illness 
trajectories, needs and configuration of services associ-
ated with diseases from each group, which when expe-
rienced together greatly increase symptom burden and 
need for care coordination. To generate this estimate, 
we calculated the mean annual change in the propor-
tion of deaths due to two or more diseases from different 
disease groups over the 11- year period. We assumed the 
mean annual change would continue to occur in a linear 
fashion and applied the resulting mean annual change 
in the proportion of deaths associated with diseases from 
different disease groups to mortality forecasts up to 2040.
Expert consultation and consensus survey
We used an abbreviated MORECare Transparent Expert 
Consultation process, consisting of a modified nominal 
group technique, to generate recommendations in 
response to projected palliative care need.15 This was 
followed by a consensus survey to rank and ascertain 
consensus on each recommendation for the future delivery 
of palliative care. A purposive sample of approximately 50 
stakeholders from palliative care, primary care and social 
care along with commissioners, service providers, govern-
ment representatives, researchers, patient/carer groups 
and charities were invited to take part. Potential partici-
pants were identified by co- authors; some were known to 
the co- authors and had participated in previous consulta-
tions. A half- day consultation took place on 3 September 
2019. Projections of future palliative care need, based 
on the quantitative data analysis, were presented. Partic-
ipants were assigned to one of four groups designed to 
maximise group heterogeneity in terms of background, 
role and experience. Each group discussed the palliative 
care need projections, critical issues emerging from the 
data and then generated recommendations in response. 
Individual participants completed a recommendations 
form in response to the question ‘What actions need 
to be prioritised to meet future palliative care need by 
2040’, and each group identified the group priorities on a 
white board during the discussion. Individual and group 
level priorities were collected. These were subsequently 
recorded in Microsoft Excel, synthesised and used to 
develop specific statements for the follow- up consensus 
survey. One month later, participants received the 
follow- up survey by email, stating the recommendations 
generated at the event. Participants were asked to rate the 
extent to which they agreed with each recommendation 
from 1 to 9 (strongly disagree to strongly agree), using 
free- text spaces to add comments explaining their judge-
ments. One completion reminder was sent after 2 weeks.
Survey data was analysed in Excel using descriptive 
statistics. Informed by guidance on consensus methods,16 
we categorised each recommendation as follows, to ascer-
tain level of agreement for each statement: scores of 1 to 3 
(recommendation not indicated), 4 to 6 (equivocal) and 
7 to 9 (recommendation indicated). We then examined 
the dispersion of scores for each statement to determine 
degree of consensus. Where the Interquartile Range 
(IQR) fell within each 3- point region outlined, we judged 
there to be ‘close agreement’ for the recommendation; 
but where ratings fell across each of these regions, we 
judged that there was ‘broad agreement’.
Patient and public involvement
A member of the Marie Curie Voices group (patient and 
carer representative group) participated in the expert 
consultation and survey and shared his perspectives on the 
meaning of the findings for patient and family care at the 
event. Three patient and public involvement representa-
tives from the Marie Curie Voices group, and one volunteer, 
commented on the draft manuscript and survey findings. 
These comments were used to inform study implications.
Reporting guidelines
We used the Strengthening the Reporting of Observa-
tional Studies in Epidemiology (STROBE) guidelines to 
inform reporting (see online supplemental file 1).
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RESULTS
Estimated palliative care need in Scotland 2007 to 2017
During this 11- year period, registered deaths in Scotland 
rose by 3.4% (55 984 to 57 870).9 Using various methods 
to estimate population level palliative care need, we esti-
mated that the number of people who died with pallia-
tive care needs in Scotland in 2017 ranged from 43 403 
(method 1) to 52 148 (method 3), an increase from 2007 
irrespective of method used (table 1). See online supple-
mental file 2 for data by year.
Projections of population level palliative care need in Scotland 
from 2018 to 2040
Deaths in Scotland are projected to reach 65 756 by 
2040, a 13.6% increase from 2017.10 Irrespective of the 
projection method used, the number of people dying of 
disease(s) associated with palliative care need is projected 
to increase. By 2040, we estimate that between 74% and 
95% of those who die might benefit from a palliative care 
approach (table 1). See online supplemental file 2 for 
data by year.
Projections of palliative care need by age group up to 2040
Based on projection method 2B, the number of people 
who die aged 0 to 74 years with palliative care needs is 
projected to fall, while those aged 75 and over will increase 
(figure 1). The greatest increase will occur for those aged 
85 and above. People aged 85 or older will account for 
just under half (47%) of those dying with palliative care 
needs by 2040 (23 491 of 50 084 projected deaths associ-
ated with palliative care need).
Projections of underlying cause of death by disease group up 
to 2040
Based on projection method 2B, deaths with cancer as the 
main underlying cause of death are projected to rise from 
16 203 in 2017 to 19 535 in 2040 (21% increase). Deaths 
where dementia is the main underlying cause of death 
are projected to rise from 6776 in 2017 to 19 284 (185% 
increase); while deaths from organ failure are projected 
to continue to fall (from 14 928 in 2017 to 9957 by 2040) 
as are deaths from other conditions requiring palliative 
care (4909 in 2017 to 1668 in 2040) (figure 2).
Proportion of people dying with multimorbidity associated 
with advanced progressive diseases across different disease 
groups
In 2017, overall, 15 725 people died with multimorbidity, 
that is, at least two diseases associated with palliative care 
need from different disease groups (27.2% of all deaths). 
The number of people projected to die with multimor-
bidity is projected to increase by 82% to 28 629 by 2040, 
accounting for 43.5% of all deaths or 45.6% of all palli-
ative care deaths using projection method 3 (figure 3). 
The proportion of those who die with multimorbidity 
is projected to increase by 60% (27.2% to 43.5%). The 
increases will mainly occur for those in the older age 
groups (figure 4). If current trends continue, by 2040, we 
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Figure 1 Projected estimates of the number of people dying in Scotland with palliative care needs by age up to 2040 using 
method 2B. Note: Data for 2007 and 2017 is actual deaths; data for 2030 and 2040 is projected deaths based on method 2B.
Figure 2 Projected main underlying cause of death associated with palliative care need by disease group up to 2040 using 
method 2B. Note: Data for 2007 and 2017 is actual deaths; data for 2030 and 2040 is projected deaths based on method 2B.
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Figure 3 Projected number and percentage of people in Scotland dying from multimorbidity associated with palliative care 
need, 2017 to 2040. Note: Data for 2007 and 2017 is actual deaths; data for 2030 and 2040 is projected deaths.
Figure 4 Projected number of people in Scotland dying from multimorbidity associated with palliative care need by age, 2017 
to 2040. Note: Data for 2007 and 2017 is actual deaths; data for 2030 and 2040 is projected. Given the small number of deaths, 
the data for the 0 to 44 age group are too small to be visible.
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or more diseases associated with palliative care need from 
different disease groups.
Expert consultation and consensus survey
Thirty- four participants participated in the consulta-
tion (online supplemental file 1) and 24 completed the 
follow- up online survey (70.5% response rate). Following 
de- duplication and synthesis of initial consultation data, 
33 potential recommendations relating to nine areas 
were identified and included in the online survey (online 
supplemental file 1). Two participants were judged to 
have misunderstood the survey rating scale as their agree-
ment scores were in the opposite direction of their free- 
text comments; these were excluded.
There was close or broad agreement that 32 of the 
33 proposed recommendations across all nine areas are 
indicated (online supplemental file 1). Recommenda-
tions relating to digital health and person- centred care 
scored most highly. Agreement scores were highest for: 
investment in a national digital health platform (M=8.5, 
SD=0.7); roll- out of shared electronic health and social 
care records across all settings (M=8.5, SD=0.9); priori-
tising the patient or family perspective; (M=8.5, SD=1.0) 
and systems promoting person- centred as opposed to 
task- oriented care (M=8.3, SD=1.1).
DISCUSSION
Principal findings
This study projects an estimate of palliative care need in 
Scotland, showing that between 14% (method 2) and 
20% (method 3 factoring in multimorbidities) more 
people may need palliative care by 2040 compared with 
2017. Cancer and dementia will increase as the main 
underlying causes of death. For the first time, we project 
multimorbidity associated with palliative care needs, 
operationalised as the proportion of people dying from 
multiple chronic progressive diseases across different 
disease groups. We show that this proportion will rise 
by 60%, accounting for nearly half of all palliative care 
deaths (46%) by 2040. Over half of those aged 85 and 
over are projected to die from multimorbidity associated 
with palliative care need, indicating increased complexity 
of needs. Experts recommended sustained investment 
in digital systems, such as electronic care coordination 
systems accessible to patients, carers and professionals, 
alongside prioritisation of person- centred approaches.
Strengths and weaknesses
We used a range of estimation methods accounting 
for both main underlying and contributory causes of 
deaths, which increases the robustness of our findings 
to inform policy and practice. The expert consultation 
and consensus survey ensured implications of the quan-
titative findings were grounded in practice. However 
future consultations should also consider including 
representatives from other professional groups including 
psychology, spiritual care and other specialities such as 
neurology and internal medicine.
Based on data available at the time of analysis, we 
applied linear models as we were primarily interested in 
projections of what may occur if recent trends continue. 
Our projections should not be interpreted as a forecast 
of what will happen, rather they provide a starting point 
for discussions around what may occur under different 
assumptions, and what actions might be needed in 
response. We used a disease count approach to estimate 
multimorbidity relevant to population palliative care 
need, as this is straightforward to estimate and replicate. 
Alternative approaches based on multimorbidity indices 
are increasingly common,17 though cannot be used with 
cause of death data alone. Our definition of multimor-
bidity was relatively restrictive—decedents were required 
to have two major illnesses from different disease groups, 
both of which would individually confer palliative care 
need. Our models draw on trends over an 11- year period, 
up to and including 2017, and project these trends 
forward. We have drawn on death registry data that relies 
on accurate completion of death certificates. We cannot 
account for changes in how cause of death is recorded 
over time, though previous changes have had minor 
impact on population level coding.18 Nor can we account 
for changes in medical treatments that may change the 
distribution of deaths by underlying cause in the future. 
Significant advances in the treatment of cancer or 
dementia might result in lower numbers dying from these 
diseases than is currently projected.
We also need to be prepared for more sudden increases 
in mortality as we have seen with COVID-19. Our esti-
mates make no adjustment for the ongoing COVID-19 
pandemic which has particularly affected people aged 
75 or over who accounted for 76% of the 4649 COVID- 
related deaths registered in Scotland by 1 November 
2020.19 Excess deaths relating to, but not directly caused 
by COVID-19, have also occurred.20 The long- term conse-
quences of the virus are not yet known though recovery 
for some is often slow and may result in longer lasting 
morbidities. This spike in deaths may be followed by 
changes in age- specific mortality rates in following 
months and years. We judge that the impact of this will 
not change the main conclusions of this paper, that the 
need for palliative care will significantly rise over the next 
20 years, with the number of people dying with complex 
needs increasing markedly.
Findings in relation to existing evidence
Our findings, that palliative care need in Scotland is 
projected to increase by 2040, reflect findings regarding 
future population palliative care need in England and 
Wales3 and in Ireland.4 As in these studies, in Scotland 
we project that the greatest increase in palliative care 
need will be for people aged 85 and above, reflecting an 
ageing population in each country. As for England and 
Wales,3 deaths where cancer and dementia is the main 
underlying cause are projected to increase, while the 
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numbers dying from organ failure as the main underlying 
cause are projected to fall. Deaths from ‘other diseases’ 
are projected to decrease, in part due to reductions in 
mortality from cerebrovascular diseases and HIV, also 
noted in the wider literature.21 22 In contrast to projec-
tions for England and Wales, based on underlying cause 
of death only,3 we did not find an increase in the propor-
tion of people dying with palliative care needs over time 
(methods 2A and 2B). This may be due in part to the 
way deaths are recorded. In Scotland, the underlying 
cause has remained stable while contributory causes asso-
ciated with palliative care needs have increased. Further 
research is needed to explore these differences.
We extended previous work, by modelling future palli-
ative care need using both main underlying cause of 
death and contributory causes (method 3). This method 
results in a higher estimate of future palliative care need 
compared with other methods that examine underlying 
cause only. Based on method 3, we estimated that in 
2017, 90% of all deaths were associated with palliative 
care need, and that this is projected to increase to 95% 
by 2040. These higher estimates are aligned with the 
maximal estimates reported by Murtagh and colleagues, 
who also used contributory cause of death to estimate 
palliative care in England and Wales for 2006 to 2008.14 
In contrast to more conservative estimates based only on 
main underlying cause only, data that also accounts for 
contributory causes show that the vast majority of people 
dying now, and in the future, may benefit from a palliative 
care approach.
Implications for clinicians, service mangers and policymakers
Multimorbidity is becoming the norm, starting earlier in 
the life course and rising steeply with age.7 23 It is widely 
recognised that health and social care services need to 
move away from a focus on care of people with single 
diseases towards systems that meet the needs of people 
with multiple diseases.6 24 Palliative care services also need 
to adapt. The hospice model is still based predominantly 
on care of people with a primary diagnosis of cancer;25 26 
specialist services need to evolve to take account of multi-
morbidity, and the associated symptom burden and uncer-
tainty, as end of life approaches. The number of people 
dying from dementia is is projected to be 2.8 times higher 
in 2040 compared with 2017, and previous research has 
shown that mental health comorbidities frequently occur 
alongside physical comorbidities.7 The palliative care 
service needs of patients or family members with dementia 
or mental health conditions need to be explicitly consid-
ered as new services are designed. More people are 
expected to die in care homes over the next two decades, 
and care homes may become the most common place of 
death in England and Wales by 2040.27 28 Multimorbidity, 
including dementia, is common among residents.29–31 
Models whereby specialist palliative care services support 
care homes to identify and provide palliative care for resi-
dents approaching end of life, alongside the broad exper-
tise from multiple disciplines, need to be commonplace.
Primary care providers need to be trained as ‘expert 
generalists’24 and need to work more closely with palli-
ative care specialists to enhance communication and 
coordination across the health and social care system. 
Electronic care coordination systems are vital to support 
coordinated care, enabling the sharing of key clinical 
information and personal preferences across all care 
settings and unscheduled care services; sustained invest-
ment in these systems is a priority.32 33 As identified previ-
ously,34–36 there is a need for palliative care education and 
training for non- specialist health and social care workers 
in all settings. Training and education in the chal-
lenges of caring for people dying with multimorbidity is 
required. This might usefully involve exposure to primary 
care, geriatrics, mental health and dementia care.37 As 
found previously,28 greater investment in increasing and 
retaining the community health and social care workforce 
to meet the projected increases in palliative care need, is 
recommended.
Unanswered questions and future research
Research on dying from multiple chronic diseases 
requiring palliative care input is needed—which combi-
nations of diseases are most prevalent, and how well 
served are those who die from multimorbidity compared 
with those with a single or dominant illness. Research 
focussing on the coexistence of mental health disorders 
with physical disorders at the end of life was not addressed 
here but needs to be prioritised in the future. We also 
need to better understand how well equipped health and 
social care professionals are to care for people with multi-
morbidity at the end of life; what types of care models are 
needed; what education, training and support is required, 
and for whom. Since the COVID-19 pandemic, research 
is required to examine the extent to which COVID-19 
has influenced mortality trends and future projections of 
palliative care need across the UK.
CONCLUSION
By 2040, irrespective of the estimation method used, 
we project that many more people in Scotland will die 
with palliative care needs, particularly in the oldest 
age groups; and care complexity will increase. Current 
models of palliative care must adapt to meet increased 
need among those aged 85 and over, most dying from 
multiple diseases, often including dementia. There is a 
need for sustained investment in a national digital health 
and social care system, that remains person- centred, to 
improve care coordination and optimise palliative care 
for people, wherever they reside.
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